This survey suggests that HIV infection in immunocompromised hosts is characterized by a high attack rate, short incubation time to clinical sequelae, and WB and RIP seropositivity which may precede evidence of antibodies by ELISA by weeks or months. The functional properties of patients' serum antibodies, such as neutralizing activity against HIV in vitro, may correlate with clinical course.
|Original language||English (US)|
|Number of pages||4|
|Journal||Hamatologie und Bluttransfusion|
|State||Published - Dec 1 1987|
All Science Journal Classification (ASJC) codes